Researchers at the Yale Cancer Center claim to have identified the molecular mechanism that enables the mutation to cause the BRCA1 gene to lose its DNA repair and tumour-fighting power" and thus trigger breast cancer. According to Patrick Sung, study senior author, results from these findings could lead to more effective drugs to treat breast and ovarian cancers.
To read more about this study, click here.
No comments:
Post a Comment